#Bioretec #Finland #Rights Offering #Helsinki #General Meeting

Bioretec Ltd Extraordinary General Meeting

Bioretec Ltd has officially announced an Extraordinary General Meeting (EGM) scheduled for March 27, 2026, at 10:00 AM Finnish time. This pivotal event will not take place at a physical venue; rather, it will be conducted as a real-time virtual meeting, adhering to the company's Articles of Association and Finnish corporate legislation.

Participation Details

Shareholders must ensure their participation by registering no later than 4:00 PM on March 19, 2026. Registration can be completed via the company's website or through email or mail, with guidelines available under section C of the meeting notice. Additionally, shareholders can vote in advance, with specific instructions also found in the same section.

Agenda Overview

The agenda for this EGM includes several key points:
1. Opening of the Meeting
2. Election of Scrutineers for Minutes and Vote Counting
3. Validation of Meeting Legality
4. Attendance Recording and Vote Adoption
5. Resolution Authorization to the Board of Directors for Rights Offering

Proposed Rights Offering

The Board of Directors will propose an authorization that would allow for the issuance of up to 1,500,000,000 new shares. This proposal is aimed at allowing existing shareholders to participate in the offering proportionally to their current holdings. Any shares not subscribed during the offering may be made available for secondary subscription by other interested parties. The terms of this offering, including the subscription period and pricing, will be determined by the Board. Importantly, this authorization is valid until June 30, 2026, and does not nullify any previously granted authorizations.

Stephen Industries Inc Oy, which holds a significant stake in Bioretec Ltd at approximately 12%, has committed to voting in favor of this proposal. Additionally, they have indicated plans to subscribe to new shares, which could potentially affect voting thresholds under Finnish law. If exercised, the commitments from Stephen Industries could have significant implications for corporate governance and share ownership distribution.

Authorization for Share Issuance

Further, the Board also seeks authorization for the issuance of shares and special rights to shares, not exceeding 250,000,000 in total. These new shares may be utilized in various corporate activities, including incentive schemes and acquisitions, enhancing the company's financial standing and operational capabilities.

Meeting Documentation

All relevant documents, in compliance with the Finnish Companies Act, will be accessible on Bioretec's corporate governance website starting on March 20, 2026. The minutes will subsequently be published by April 10, 2026.

Instructions for Shareholders

To attend the EGM, shareholders must be officially registered by March 17, 2026. Participation can be accomplished via virtual means, with detailed technical requirements provided to ensure seamless involvement. Shareholders with nominee-registered shares are advised to consult their custodian bank for registration and voting instructions.

Proxy representation will also be permissible, contingent on the provision of suitable documentation. Detailed instructions for both participation and proxy voting are included in the official meeting notice, accessible on the company’s website.

Given the ongoing developments within Bioretec Ltd, this EGM presents a potential turning point for investors and stakeholders alike, indicating a strategic approach towards enhancing shareholder engagement and corporate growth.

For further inquiries about the meeting, shareholders are encouraged to contact Bioretec's Executive Management, ensuring they are well-informed ahead of this critical gathering